BioHorizons announces new products for dental implant site development procedures

October 10, 2014

BioHorizons has announced the launch of MinerOss® X, a family of xenograft products for dental implant site development procedures. 

BioHorizons has announced the launch of MinerOss® X, a family of xenograft products for dental implant site development procedures. 

The MinerOss® X family includes cancellous or cortical particulate, a moldable collagen block and a cancellous particulate pre-loaded into a delivery syringe to assist with optimal placement.  It is designed for extraction sockets, grafting for implant placement, ridge augmentation, and sinus augmentation. 

Trending article: How to cement posterior crowns [VIDEO]

"MinerOss X represents a significant addition to our innovative tissue regeneration product portfolio," said Steve  Boggan, President and CEO of BioHorizons. "MinerOss X is a xenograft alternative for predictable bone regeneration and complements our highly successful line of MinerOss allografts.  With this product line, BioHorizons offers dentists the most complete portfolio of regenerative hard and soft tissue grafting products." 

MinerOss X particulates range in size from 250 to 1000 microns providing excellent handling characteristics for a wide variety of regeneration procedures.  MinerOss X particulate is available in 0.25g, 0.5g, 1.0g and 2.0g easily accessible vials with a convenient screw-top lid.  MinerOss X syringe is available in 0.25cc, 0.5cc and 1.0cc sizes for added convenience during surgery.  MinerOss X collagen is also available in three sizes to support large and small grafting cases.

Trending article: Discussing current hot topics in dental infection control